Literature DB >> 6412393

Platelet aggregation studies in whole human blood.

A R Saniabadi, G D Lowe, C D Forbes, C R Prentice, J C Barbenel.   

Abstract

Since the development of the photometric aggregometer, platelet aggregation studies are routinely performed on platelet-rich plasma (PRP). We have studied platelet aggregation in fresh citrated whole human blood using the recently developed Ultra Flo 100 Whole Blood Platelet Counter. Aggregation of platelets in whole blood was induced with adenosine 5'-diphosphate (ADP; 0.25-10 microM), collagen (0.25-1.0 microgram/ml) and thrombin (0.05-0.2U/ml). Platelet aggregation induced by ADP and thrombin was maximum within 1 min, and that of collagen within 3 mins. Aggregation responses to low concentration of ADP and thrombin were rapidly reversible, whereas responses to collagen and high concentrations of ADP and thrombin were virtually irreversible. The aggregation of platelets was indicated by a fall in platelet count; confirmed by scanning electron micrographs which revealed the presence of large aggregates of platelets, and was prevented when blood was treated with EDTA as anticoagulant. The present technique appears to be rapid, sensitive and reliable; and allows direct measurement of platelet aggregation and disaggregation in whole blood in vitro and ex-vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6412393     DOI: 10.1016/0049-3848(83)90271-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Temporal aggregate size distributions from simulation of platelet aggregation and disaggregation.

Authors:  P D Nguyen; E A O'Rear
Journal:  Ann Biomed Eng       Date:  1990       Impact factor: 3.934

Review 2.  Platelet function tests in the assessment of antithrombotic agents.

Authors:  M Greaves
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

3.  Histones induce rapid and profound thrombocytopenia in mice.

Authors:  Tobias A Fuchs; Ashish A Bhandari; Denisa D Wagner
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

4.  Mechanisms of hemolysis-associated platelet activation.

Authors:  C C Helms; M Marvel; W Zhao; M Stahle; R Vest; G J Kato; J S Lee; G Christ; M T Gladwin; R R Hantgan; D B Kim-Shapiro
Journal:  J Thromb Haemost       Date:  2013-12       Impact factor: 5.824

5.  Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers.

Authors:  J J Belch; M McLaren; C S Lau; I R Mackay; A Bancroft; J McEwen; J M Thompson
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

6.  Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo.

Authors:  R F Booth; A C Honey; N Lad; D P Tuffin; P J Wade
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.